Why the study?
Cardiomyopathies are heterogeneous, and advances in genetic testing enable establishing genotype-phenotype relationships to determine prognosis and specific treatments in pediatric patients.
Genetic testing and establishing genotype-phenotype relationships are important for determining prognosis and guiding therapy in pediatric cardiomyopathies.
Answers are grounded in this paper and cite their sources.
Supports genotype-guided care in pediatric cardiomyopathy; extends adult data but leaves open need for prospective validation.
Cardiomyopathies constitute a heterogeneous group of diseases with varying etiologies and clinical presentation. Advances in genetic testing have made it possible to establish genotype-phenotype relationships, determine prognosis, and choose specific treatments in the pediatric population. Therefore, the objective of this review is to assist clinical reasoning and underscore the importance of etiological diagnosis in different disease phenotypes.
No takes yet. Share an insight, caveat, or question.
Torbey et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: